Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

被引:180
作者
Sanchez, A
Yang, ZY
Xu, L
Nabel, GJ
Crews, T
Peters, CJ
机构
[1] Ctr Dis Control & Prevent, Special Pathogens Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Biotechnol Core Facil, Sci Resources Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[3] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/JVI.72.8.6442-6447.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The glycoproteins expressed by a Zaire species of Ebola virus were analyzed for cleavage, oligomerization, and other structural properties to better define their functions. The 50- to 70-kDa secreted and 150-kDa virion/structural glycoproteins (SGP and GP, respectively), which share the 295 N-terminal residues, are cleaved near the N terminus by signalase, A second cleavage event, occurring in GP at a multibasic site (RRTRR down arrow) that is likely mediated by furin, results in two glycoproteins (GP1 and GP2) linked by disulfide bonding. This furin cleavage site is present in the same position in the GPs of all Ebola viruses (R[R/K]X[R/K]R down arrow), and one is predicted for Marburg viruses (R[R/K]KR down arrow), although in a different location. Based on the results of cross-linking studies, we were able to determine that Ebola virion peplomers are composed of trimers of GP1-GP2 heterodimers and that aspects of their structure are similar to those of retroviruses, paramyxoviruses, and influenza viruses. We also determined that SGP is secreted from infected cells almost exclusively in the form of a homodimer that is joined by disulfide bonding.
引用
收藏
页码:6442 / 6447
页数:6
相关论文
共 27 条
[11]  
Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6
[12]   ENZYME IMMUNOSORBENT-ASSAY FOR EBOLA VIRUS-ANTIGENS IN TISSUES OF INFECTED PRIMATES [J].
KSIAZEK, TG ;
ROLLIN, PE ;
JAHRLING, PB ;
JOHNSON, E ;
DALGARD, DW ;
PETERS, CJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (04) :947-950
[13]  
Peter CJ, 1996, FIELDS VIROLOGY, P1161
[14]  
Ruiz-Argüello MB, 1998, J VIROL, V72, P1775
[15]   SEQUENCE-ANALYSIS OF THE EBOLA VIRUS GENOME - ORGANIZATION, GENETIC ELEMENTS, AND COMPARISON WITH THE GENOME OF MARBURG VIRUS [J].
SANCHEZ, A ;
KILEY, MP ;
HOLLOWAY, BP ;
AUPERIN, DD .
VIRUS RESEARCH, 1993, 29 (03) :215-240
[16]   Variation in the glycoprotein and VP35 genes of Marburg virus strains [J].
Sanchez, A ;
Trappier, SG ;
Stroher, U ;
Nichol, ST ;
Bowen, MD ;
Feldmann, H .
VIROLOGY, 1998, 240 (01) :138-146
[17]   The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing [J].
Sanchez, A ;
Trappier, SG ;
Mahy, BWJ ;
Peters, CJ ;
Nichol, ST .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3602-3607
[18]   VACCINIA-VECTORED EXPRESSION OF THE RUBELLA-VIRUS STRUCTURAL PROTEINS AND CHARACTERIZATION OF THE E1-GLYCOSIDIC AND E2-GLYCOSIDIC LINKAGES [J].
SANCHEZ, A ;
FREY, TK .
VIROLOGY, 1991, 183 (02) :636-646
[19]  
*SIGM CHEM CO, 1988, TECHN B
[20]   THE ENVELOPE GLYCOPROTEIN OF EBOLA VIRUS CONTAINS AN IMMUNOSUPPRESSIVE-LIKE DOMAIN SIMILAR TO ONCOGENIC RETROVIRUSES [J].
VOLCHKOV, VE ;
BLINOV, VM ;
NETESOV, SV .
FEBS LETTERS, 1992, 305 (03) :181-184